Intravenous 2-Chloroadenosine Protects BALB/C Mice from Klebsiella pneumoniae B5055-Induced Sepsis by Modulating the Pro-Inflammatory Immune Response

REFERENCES

• Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abra-ham E, Trzeciak S, et al. Severe sepsis and septic shock: review of the literature and emergency department management guide-lines. Annals Emerg Med 2006; 48 (1): 28–54.
   PubMed Web of Science ®Google Scholar
• Alberti C, Brun-Buisson C, Burchardi H, Martin C, Good-man S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. In-tensive Care Med 2002; 28: 108–121.
   PubMed Web of Science ®Google Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Car-cillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–1310.
   PubMed Web of Science ®Google Scholar
• Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885–891.
   PubMed Web of Science ®Google Scholar
• Hasko G, Szabo C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 1998; 56: 1079–1087.
   PubMed Web of Science ®Google Scholar
• Hasko G, Deitch EA, Szabo C, Nemeth ZH, Vizi ES. Adenosine: a potential mediator of immunosuppression in mul-tiple organ failure. Curr Opin Pharmacol 2002; 2: 440–444.
   PubMed Web of Science ®Google Scholar
• Sperlagh B, Doda M, Baranyi M, Hasko G. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J. Neuroimmunol 2000; 111: 45–54.
   PubMed Web of Science ®Google Scholar
• Martin C, Leone M, Viviand X, Ayen ML, Guieu R. High adenosine plasma concentration as a prognostic index for out-come in patients with septic shock. Crit Care Med 2000; 28: 3198–3202.
   PubMed Web of Science ®Google Scholar
• Sperlagh B, Hasko G, Nemeth Z, Vizi ES. ATP released by LPS increases nitric oxide production in rat 264.7 macrophage cell line via P2Z/F'2X7 receptors. Neurochem Int 1998; 33: 209–215.
   Google Scholar
• Bodin P, Burnstock G. Increased release of ATP from en-dothelial cells during acute inflammation. Inflamm Res 1998; 47 351–354.
   PubMed Web of Science ®Google Scholar
• Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004; 22: 657 682.
   Google Scholar
• Cavalcante IC, Castro MV, Barreto ARF, Sullivan GW, Vale M, Almeida PRC, et al. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-in-duced murine ileal enteritis. Infect Immun 2006; 74 (5): 2606–2612.
   PubMed Web of Science ®Google Scholar
• Wu X, Kenter R, Stezoski J, Kocanek PM, Jackson EK, Carlos TM, et al. Intraperitoneal, but not enteric, adenosine ad-ministration improves survival after volume-controlled hemorrhagic shock in rats. Crit Care Med 2001; 29: 1767–1773.
   PubMed Web of Science ®Google Scholar
• DeMarsh PL, Wells GI, Lewandowski TF, Frey CL, Bhat-nagar PK, Ostovic EJR. Treatment of experimental gram-nega-tive and gram positive bacterial sepsis with the hemoregulatory peptide SK&F 107647. J Infect Dis 1996; 173: 203–211.
   PubMed Web of Science ®Google Scholar
• Toky V, Sharma S, Arora BB, Chhibber S. Establishment of sepsis model following implantation of Klebsiella pneumo-niae-infected fibrin clot into the peritoneal cavity of mice. Folia Microbiol 2003; 48 (5): 665–669.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Strieter RM, Zisman DA, Witkowski JM, Buck-nell KA, Chen G, et al. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 1997; 65: 1870–1875.
   PubMed Web of Science ®Google Scholar
• Sullivan GW, Fang G, Linden J, Scheid MW. A2A adeno-sine receptor activation improves survival in mouse models of en-dotoxemia and sepsis. J Infect Dis 2004; 189: 1897-904.
   Google Scholar
• Stamler JS, Single DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258: 1898–1902.
   PubMed Web of Science ®Google Scholar
• Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K-I. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exper Ther 2000; 294; 1043–1046.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Zhang H, Szabo, et al. Effects of nitric oxide in septic shock. Am J Respire Crit Care Med 2000; 161: 1781–1785.
   PubMed Web of Science ®Google Scholar
• Dhillon SS, Mahadevan K, Sandi V, Zheng Z, Smith W, Rumbaut RE. Neutrophils, nitric oxide, and microvascular per-meability in severe sepsis. Chest 2005; 128: 1706–1712.
   PubMed Web of Science ®Google Scholar
• Nava E, Salazer FJ. Comparative effects of nitric oxide synthesis inhibition and catecholamine treatment in a rat model of endotoxin shock. Eur J Clin Invest 1997; 27: 673–679.
   PubMed Web of Science ®Google Scholar
• Avontuur JA, Stam TC, Jongen-Lavrecic Metal. Effect of L-NME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF-or and nitrite/nitrate in human septic shock. In-tensive Care Med 1998; 24: 673–679.
   PubMed Web of Science ®Google Scholar
• Petros A, Bennett D, Valiance P. Effect of nitric oxide syn-thase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–1558.
   PubMed Web of Science ®Google Scholar
• Farley KS, Wang LF, Razavi HM, Law C, Rohan M, Mc-Cormack DG, Mehta S. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1164–L1172.
   PubMed Web of Science ®Google Scholar
• Kristof AS, Goldberg P, Laubach V, Hussain SNA. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1998; 158: 1883–1889.
   PubMed Web of Science ®Google Scholar
• Baron RM, Carvajal IM, Liu X, Okabe RO, Fredenburgh LE, MaciasAA, et al. Reduction of nitric oxide synthase 2 ex-pression by distamycin A improves survival from endotoxemia. J Immunol 2004; 173: 4147-4153.
   Google Scholar
• Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores S, McCarthy, et al. Adenosine receptor agonists differentially regu-late IL-10, TNF-a, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996; 157: 4634–4640.
   Google Scholar
• Jordan JE, Zhao Z-H, Sato H, Taft S, Vinten-Johansen J. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exper Ther 1997; 280: 301–309.
   PubMed Web of Science ®Google Scholar
• Yan L, Burbiel JC, MaaB A, Muller CE. Adenosine receptor agonists: from basic medicinal chemistry to clinical devel-opment. Expert Opin Emerg Drugs 2003; 8 (2): 537–576.
   PubMedGoogle Scholar
• Sakamaki F, Ishizaka A, Urano T, Sayama K, Nakamura H, Tershima T, et al. Attenuation by intravenous 2-chloroadeno-sine of acute lung injury by live Escherichia coil or latex particles added to endotoxin in the neutropenic state. J Lab Clin Med 2003; 142: 128–135.
   PubMed Web of Science ®Google Scholar
• Parmenly MJ, Zhou W-W, Edwards III CK, Borchenerd-ing DR, Silverstein R, Morrison DC. Adenosine and related car-boxylic nucleoside analogue selectively inhibit tumor necrosis factor-a production and protect mice against endotoxin chal-lenge. J Immunol 1993; 151: 389–396.
   PubMed Web of Science ®Google Scholar
• Bouma MG, Stad RK, van den Wildenberg Frans AJM, Buurman WA. Differential regulatory effect of adenosine on cy-tokine release by activated human monocytes. J Immunol 1994; 153: 4159–4168.
   PubMed Web of Science ®Google Scholar
• Spight D, Zhao B, Haas M, Wert S, Denenberg A, Shan-ley TP. Immunoregulatory effects of regulated, lung-targeted ex-pression of IL-10 in vivo. Am J Physiol Lung Cell Mol Physiol 2005; 288: L251—L265.
   PubMed Web of Science ®Google Scholar
• Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG im-mune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997; 159: 3483-3489.
   Google Scholar
• Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-in-duced lung injury. J Immunol 1995; 154: 3454-3460.
   Google Scholar
• Reutershan J, Cagnina RE, Chang D, Linden J, Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2A stimulation in lipopolysaccharide-induced lung in-jury. J Immunol 2007; 179: 1254-1263.
   Google Scholar
• Lukashev D, Ohta A, Apasov S, Chen J-F, Sitkovsky MV. Cutting Edge: Physiologic attenuation of proinflammatory tran-scription by the G, protein-coupled A2A adenosine receptor In vivo. J Immunol 2004; 173: 21–24.
   PubMed Web of Science ®Google Scholar
• Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangio-genic matrix protein thrombospondin 1. Mol Pharmacol 2005; 67: 1406-1413.
   Google Scholar